iBio, Inc. (NASDAQ:IBIO) Given Consensus Rating of "Buy" by Analysts
Shares of iBio, Inc. (NASDAQ:IBIO - Get Free Report) have earned an average recommendation of "Buy" from the six research firms that are covering the company, MarketBeat.com reports. One analyst has...